Statistics for 3- year efficacy and safety for liraglitude 3.0mg in adults with obesity/overweight, prediabetes and baseline BMI <35 vs >/=35kg/m2 in the SCALE obesity and and pore diabetes, double-blind, placebo-controlled trial
Total visits
| views | |
|---|---|
| 3- year efficacy and safety for liraglitude 3.0mg in adults with obesity/overweight, prediabetes and baseline BMI <35 vs >/=35kg/m2 in the SCALE obesity and and pore diabetes, double-blind, placebo-controlled trial | 1 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| 3-year efficacy and safety for liraglutide 3.0mg in adults.pdf | 29 |
Top country views
| views | |
|---|---|
| Russia | 1 |
Top city views
| views | |
|---|---|
| Moscow | 1 |